Agents for the treatment of lower abdominal disorders
AssigneeAtlanta Pharma AG
InventorsUrsula Gebauer, Iris Velten, Wolfgang-Alexander Simon
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of pantoprazole in the treatment of lower abdominal disorders.
Claims30
(canceled)
(canceled)
A method of treating a lower abdominal disorder in a patient comprising administering to a patient in need thereof a therapeutically effective amount of a proton pump inhibitor, or a hydrate, solvate, salt, hydrate of a salt or solvate of a salt thereof.
(canceled)
(canceled)
A ready-to-use medicament comprising a proton pump inhibitor as active compound, or a hydrate, solvate, salt, hydrate of a salt or solvate of a salt thereof, and a reference to the fact that it can be employed for the treatment of lower abdominal disorders.
(canceled)
A method of treating a lower abdominal disorder in a patient comprising administering to a patient in need thereof a therapeutically effective amount of pantoprazole, or a hydrate, solvate, salt, hydrate of a salt or solvate of a salt thereof.
(canceled)
(canceled)
A ready-to-use medicament comprising pantoprazole as active compound, or a hydrate, solvate, salt, hydrate of a salt or solvate of a salt thereof, and a reference to the fact that it can be employed for the treatment of lower abdominal disorders.
A ready-to-use medicament for the treatment of lower abdominal disorders comprising pantoprazole, or a hydrate, solvate, salt, hydrate of a salt or solvate of a salt thereof, as one active compound and a second active compound selected from aminosalicylates glucocorticoids, immunosuppressive agents pharmaceuticals for the treatment of diarrhoeas and pharmaceuticals for the treatment of IBS.
(canceled)
Dependencies are inferred from the claim text.